SCHEMBL1486594

SCHEMBL1486594

Cc1nc2c(N)nc3ccc(OCc4ccccc4)cc3c2n1CCCCNC(=O)Nc1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
FAAH O00519 1/20 0.47
MAPT P10636 3/20 0.45
TLR7 Q9NYK1 8/20 0.44
BRD4 O60885 2/20 0.43
KMT2A Q03164 2/20 0.43
MEN1 O00255 1/20 0.43
TLR8 Q9NR97 1/20 0.40
GBA1 P04062 1/20 0.40
KDM4E B2RXH2 2/20 0.40
LMNA P02545 1/20 0.40
POLB P06746 1/20 0.40
HTT P42858 1/20 0.40
RAB9A P51151 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
USP2 O75604 1/20 0.39
CASP1 P29466 1/20 0.39
CASP7 P55210 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL1486610 0.91 TLR7 (0.50) TLR7KMT2ATLR8
SCHEMBL1486616 0.89 TLR7 (0.47) TLR7KMT2ATLR8
SCHEMBL1486495 0.89 TLR7 (0.54) TLR7TLR8
SCHEMBL1486512 0.89 TLR7 (0.47) TLR7BRD4TLR8
SCHEMBL1486631 0.88 FAAH (0.52) FAAHMAPTTLR7BRD4KDM4E
SCHEMBL5356533 0.85 FAAH (0.59) FAAHMAPTTLR7TLR8KDM4E
SCHEMBL1486611 0.84 NMT2 (0.44) MAPTTLR7TLR8KDM4ELMNA
SCHEMBL1486595 0.84 TLR7 (0.56) TLR7KMT2AMEN1TLR8RAB9A
SCHEMBL1486651 0.83 TLR7 (0.50) TLR7KMT2AMEN1TLR8RAB9A
SCHEMBL1486535 0.81 TLR7 (0.46) TLR7KMT2AMEN1TLR8RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1658076-B1 ARYLOXY AND ARYLALKYLENEOXY SUBSTITUTED IMIDAZOQUINOLINES 3M INNOVATIVE PROPERTIES CO (US) 2013-03-06 EP disclosed
US-8263594-B2 Aryloxy and arylalkyleneoxy substituted imidazoquinolines 3M INNOVATIVE PROPERTIES COMPANY (US) 2012-09-11 US disclosed
US-20110144099-A1 ARYLOXY AND ARYLALKYLENEOXY SUBSTITUTED IMIDAZOQUINOLINES 3M INNOVATIVE PROPERTIES COMPANY 2011-06-16 US disclosed
US-7897597-B2 Aryloxy and arylalkyleneoxy substituted imidazoquinolines 3M INNOVATIVE PROPERTIES COMPANY (US) 2011-03-01 US disclosed
US-20090018122-A1 Aryloxy and Arylalkyleneoxy Substituted Imidazoquinolines 3M INNOVATIVE PROPERTIES COMPANY 2009-01-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090018122-A1 Aryloxy and Arylalkyleneoxy Substituted Imidazoquinolines IL2, IFNG, IRF3 FAAH 2520/4885MAPT 4765/4885TLR7 45/4885
US-20110144099-A1 ARYLOXY AND ARYLALKYLENEOXY SUBSTITUTED IMIDAZOQUINOLINES IL2, IFNG, IRF3 FAAH 2539/4885MAPT 4760/4885TLR7 42/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.